Mankind Pharma launches campaign to inspire 1 crore Indians to pledge for organ donation

In a step towards addressing India’s critical need for organ donors, Mankind Pharma Limited, one of India’s leading pharmaceutical companies, has launched its nationwide public awareness campaign “Angdaan Mahadaan”, with a goal of inspiring 1 crore Indians to pledge for organ donation.

The campaign was launched in the presence of transplant specialists and dignitaries from the National Organ and Tissue Transplant Organisation (NOTTO), who came together to raise public awareness, dispel myths and highlight the transformative impact of organ donation.

Through “Angdaan Mahadaan”, Mankind Pharma aims to create greater awareness, address myths and misconceptions, and motivate millions of Indians to turn public awareness into meaningful action.

The campaign was launched at an Organ Donation Awareness Event hosted by Mankind Pharma, engaging more than 25,000 Mankindians, their families and extended communities. The event featured sessions on the realities of organ donation, myths and facts surrounding transplantation, and the current organ donation landscape in India.

The event brought together Dr D S Ray, chief nephrologist and head, renal transplant programme, R N Tagore International Institute of Cardiac Sciences, Narayana Health, Kolkata; Dr. Abhideep Chaudhary, chairman and HOD, HPB Surgery and Liver Transplantation, BLK-Max Super Speciality Hospital, New Delhi; and Dr. Kanika Rastogi, National Organ and Tissue Transplant Organisation (NOTTO), New Delhi to raise public awareness about the importance of organ donation.

“To give is to live beyond yourself. Through Angdaan Mahadaan, we want to inspire people across India to recognise the extraordinary power of a simple decision: the decision to give someone another chance at life. Our ambition is to motivate 1 crore Indians to pledge for organ donation and make this a movement that creates a lasting legacy of hope,” said Rajeev Juneja, vice chairman and managing director, Mankind Pharma Ltd.

  • Related Posts

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from…

    Lupin gets tentative US FDA nod for apixaban oral suspension for patients who cannot swallow tablets

    Once final approval comes through, the liquid anticoagulant will be made at Lupin’s plant in Somerset, New Jersey, the company said. Mumbai: Lupin has received tentative approval from the US…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Delhi High Court sets aside FSSAI order asking Red Bull India to drop ‘energy’ from its drinks

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Haryana to use Ayushman, Chirayu claim money for hospital staff incentives and upgrades: CM

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Indian speciality drugs get zero duty as US widens 100% tariff on patented medicines

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Low-dose CT screening lowers lung cancer deaths by 16% in high-risk people: IARC

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore

    Krsnaa Diagnostics board clears sale of diagnostic equipment worth up to Rs 120 crore